Cva Family Office, LLC Catalent, Inc. Transaction History

Cva Family Office, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$31.86 - $67.26 $5,097 - $10,761	-160 Reduced 86.49%	25 $1,000
Q1 2023 Apr 26, 2023	BUY	$45.44 - $74.26 $2,726 - $4,455	60 Added 48.0%	185 $12,000
Q4 2022 Feb 21, 2023	BUY	$41.39 - $81.0 $4,139 - $8,100	100 Added 400.0%	125 $5,000
Q3 2022 Nov 22, 2022	SELL	$72.36 - $113.1 $5,065 - $7,917	-70 Reduced 73.68%	25 $2,000
Q2 2022 Jul 11, 2022	BUY	$87.2 - $114.05 $2,180 - $2,851	25 Added 35.71%	95 $10,000
Q1 2022 Apr 22, 2022	BUY	$94.19 - $124.49 $6,593 - $8,714	70 New	70 $8,000
Q2 2021 Jul 13, 2021	SELL	$100.34 - $115.69 $5,518 - $6,362	-55 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$101.51 - $125.27 $5,583 - $6,889	55 New	55 $6,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.